Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Research Models
Alpha-Synuclein Research Models

Updated 26 May 2009

back to Research Models Index

Viewing tips: Make your browser window wide enough to view the table, which should fit on most standard monitors. 

 
Name/
Symbol
Strain Name Transgene/
Promoter and Regulatory Elements
Genetic Background Behavioral 
Phenotype
Neurological 
Characteristics
Patents/ 
Availability
Primary Citation
β-Synuclein

Symbol: bSYN

Posted 05/26/09

B6.129-Sncbtm1Sud/J Introduced loxP sites on either side of exon 2 (residues 1-41)/bred with mice expressing cre, thus removing floxed exon 2 /(129X1/SvJ x 129S1/Sv)F1-Kitl +-derived R1-ES cells. Origin: (129X1/SvJ x 129S1/Sv)F1-Kitl<+>. Generation: N5pN1. Backcrossed: C57BL/6. Homozygous mice are viable, normal in size and do not display any gross physical or behavioral abnormalities, but breed very poorly. When bred to a strain expressing Cre recombinase, this mutant mouse strain may be useful in studies of presynaptic proteins and synaptic vesicles. The Jackson Lab, cryopreserved, Stock #008133. Use of mice by companies or for-profit entities requires a license prior to shipping. Chandra et al., 2004
α/β-Synuclein ko

Symbol: aSYN-bSYN

Posted 05/26/09

B6;129-Sncatm1Sud Sncbtm1.1Sud/J First mutation SNCA gene: first coding exon (residues 1-40), deleted via homologous recombination/electroporated into 129P2/OlaHsd ?derived E14.1 ES cells/injected into C57BL/6 blastocysts/crossed with C57BL/6 mice. Second mutation SNCB gene stock # 8133. Mice carrying the independent targeted mutation genes were intercrossed to generate animals with both mutations. Origin: 129P2/OlaHsd/ (129X1/SvJ x 129S1/Sv)F1-Kitl<+>. Generation: N?+N1F7 (16-Apr-09). Homozygous mice are viable and fertile and do not display any gross physical or behavioral abnormalities. Overall brain morphology and structure normal. Dopamine levels in the mice decreased by ~20 percent, but dopamine uptake and release from isolated nerve terminals is normal. Serotonin levels are unchanged. The Jackson Lab, available, stock #006390. Use of mice by companies or for-profit entities requires a license prior to shipping. Chandra et al., 2004
α-Synuclein (A53T mutation) Line 53

Symbol: aSYN

Posted 05/26/09

B6.Cg-Tg(THY1-SNCA*A53T)M53Sud/J/J Mouse SNCA (synuclein, alpha) gene/human THY1 (thymus cell antigen 1, theta) promoter. Origin: unknown. Generation: N5+F2 (02-Jan-09). Hemizygous mice are viable and fertile. Hind limb paralysis due to loss of motor neurons and a resting tremor seen ~6 months. Parkinson-like phenotype upon aging. Cell death in the spinal cord (extensive) and brain. No Lewy body-like pathology. The Jackson Lab, available, stock #008135. Use of mice by companies or for-profit entities requires a license prior to shipping. Chandra et al., 2005
α-Synuclein (huA30P mutation) Line M30

Symbol: aSYN

Posted 05/26/09

B6.Cg-Tg(THY1-SNCA*A30P)M30Sud/J/J Human A30P mutant SNCA (synuclein, alpha) gene/human THY1 (thymus cell antigen 1, theta) promoter/injected into B6SJLF1/J embryos, backcrossed ~10 times to C57BL/6. Origin: (C57BL/6J x SJL/J)F1. Generation: N11+F (15-Jan-09). Hind limb mobility problems and a resting tremor phenotype at 10 months due to a loss of motor neurons. Mice live 14 months. Expression of the transgene is fivefold higher in the brain and 10-fold higher in the spinal cord. No Lewy body-like pathology. The Jackson Lab, available, stock #008473. Use of mice by companies or for-profit entities requires a license prior to shipping. Chandra et al., 2005
Tg(THY1-SNCA)1Sud

Symbol: aSYN

Posted 05/26/09

C57BL/6-Tg(THY1-SNCA)1Sud/J/J HuSNCA gene/THY1 promoter. Generation: N?pN1. Hemizygotes are viable and fertile; mice show onset of motorneuron disease at ~5-6 months. Levels of expression show a 5-fold increase in the brain and a 10-fold increase in the spinal cord. The Jackson Lab, cryopreserved, stock #008389. Use of mice by companies or for-profit entities requires a license prior to shipping. Chandra et al., 2005
α-SYN ko

Symbol: aSYN

Posted 05/26/09

B6;129X1-Sncatm1Rosl/J PGK-neo cassette used to delete exons 1 and 2 (aa 1-41)/phosphoglycerate 1 promoter/RW-4 ES cells/injected into C57BL/6 blastocysts. Origin: 129X1/SvJ. Generation: [F8p]+F7 (24-Dec-08). Homozygous null mice are viable, fertile, normal in size and do not display any gross abnormalities. No gene product detected in brain tissue. A wildtype complement of dopamine neurons, fibers and synaptic terminals is present and the overall brain architecture appears intact. There is a reduction in total striatal dopamine. Available
The Jackson Lab, stock #003692. Use of mice by companies or for-profit entities requires a license prior to shipping.
Abeliovich et al., 2000
α-Synuclein, M1m

Symbol: aSYN

Posted 05/26/09

STOCK Tg(THY1-Snca)M1mSud/J Mouse Snca (synuclein, alpha) cDNA/ mouse Thy1 (thymus cell antigen 1, theta) promoter/ insertion M1m. Origin: unknown. Generation: N?+N1F2 (28-Jan-09). Backcrossed: C57BL/6. Mice hemizygous for this transgene are viable and fertile and do not display any gross physical or behavioral abnormalities, even upon aging. *Normal* nervous system phenotype, mice do not develop motoneuron disease. Available
The Jackson Lab, stock #008132. Use of mice by companies or for-profit entities requires a license prior to shipping.
Chandra et al., 2005
A53T αsynuclein PRP transgenic-/-
(See JAX datasheet)

Symbol: SNCA

Updated 3/16/09

B6;C3-Tg(Prnp-SNCA*A53T)83Vle/J Mouse Prnp, prion protein promoter/ human α-synuclein A53T mutation cDNA /B6C3H mouse eggs. Origin: C57BL/6 x C3H; Designation: Line 83. Generation: N?+N7F4 (01-Jan-09). Homozygous mice are viable, fertile and normal in size. By 16 months display severe motor phenotype. Lax grooming, weight loss and diminished mobility precede movement impairment, partial limb paralysis, trembling and inability to stand. 8 to 12 months widely distributed α-synuclein inclusions, with dense accumulation in the spinal cord, brainstem, cerebellum and thalamus. This parallels the onset of the motor impairment phenotype. Axons and myelin sheaths exhibit progressive ultrastructural degeneration. Available
The Jackson Lab: Stock 004479. Use by companies or for-profit entities requires a license prior to shipping.
Giasson et al., 2002
Alpha Synuclein   Human alpha-synuclein cDNA with A53T mutation/
Thy1 gene promoter
C57BL/6 An early-onset (>3 weeks of age) and a progressive decline of motor function caused by severe degeneration of neuromuscular junctions. Increased levels of a-synuclein protein in brain found in neurons throughout the telencephalon, brainstem, and spinal cord. Also showed astrocytic gliosis and microglial activation. Many of the cells showed diffuse perikaryal a-synuclein staining. Intense staining with the Campbell-Switzer pyridine silver, a routine and sensitive method used to detect Lewy-type changes in human brain tissue. Unpatented van der Putten H et al., 2000;

Sommer B et al., 2000

(PLP)-h[wt] αSYN

Symbol: αSYN

Updated 4/14/05

  Human wt αSYN / proteolipid protein promoter (PLP)/injected into C57BL/6 DBA/2 fertilized eggs. Origin: C57BL/6. Backcross generation N7   Transgenic SYN was detected in brain white matter and oligodendrocytes, detergent insoluble. Hyperphosphorylation at S129 of SYN in the tg mice. Contact Philipp Kahle
at pkahle@pbm.med.uni-muenchen.de
Kahle et al., 2002
(TH)-h[A30P] SYN

Symbol: αSYN

Posted 7/9/04

  human mutant [A30P] SYN sequence was cloned into a cassette with 4.5-kb 5' flanking DNA from rat TH gene promotor/Injected DBA X C57BL/6 eggs. Origin: C57BL/6; Backcrossed to 4 generations No motor disability Tg mice showed somal and neuritic accumulation of transgenic A30P SYN in TH-positive neurones in the substantia nigra. No difference in the number of TH-positive neurones or concentrations of catecholamines between tg mice and non-tg littermates. Contact Philipp Kahle
at pkahle@pbm.med.uni-muenchen.de
Rathke-Hartlieb et al., 2001
(Thy1)-h[A30P] SYN

Updated 4/14/05

  The amplified human [wt]Alpha-SYN-coding sequence with A30P mutation/ neuron specific Thy1 promoter Backcrossed N > 8 generations C57BL/6J, (2002) No overt motor abnormalities to 1 year of age. Shows age-gene-dose dependent lethal locomotor deterioration along with Lewy pathology. Mutant hα-SYN found in synapses, and positive neurites exhibit Lewy body characteristics. Shows age- and gene dose- dependent development of Lewy pathology. Unpatented

Contact: Philipp Kahle

Kahle et al., 2000
(Thy1)-h[wt] αSYN

Updated 11/4/03

  human wild-type α-SYN cDNA C57BL/6 None listed. hα-SYN initially undetectable but then increased to plateau at 1 month, expression was 3 fold of endogenous α-SYN. Abnormal Tg α-syn-positive neurites were seen. Tg α-syn found in detergent-insoluble tissue fractions.

Contact: Philipp Kahle

Kahle et al., 2001

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark

See recent updates
Alzheimer's Disease Mouse Model Resource
Considerations for Choosing Controls
Research Tools

Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad